Per Stål

15PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersHaematological tumoursFood properties (incl. characteristics and health benefits)Cardiology (incl. cardiovascular diseases)Counselling, wellbeing and community services
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 02, 2026
Pembrolizumab Monotherapy in Sorafenib-Treated and Treatment-Naïve Advanced Hepatocellular Carcinoma: Long-Term Follow-up of the Open-Label, Phase II KEYNOTE-224 Study.

Richard S Finn, Masatoshi Kudo, Ivan Borbath

|Nov 26, 2025
Associations of S-Adenosylmethionine and S-Adenosylhomocysteine with Hepatocellular Carcinoma.

Naana N Yalley, Sebastian M Armasu, Winnie Z Fan

|Aug 13, 2025
One-year follow-up of short-term dietary intervention for MASLD: sustained improvements in steatosis, weight and dietary intake.

Magnus Holmer, Hannes Hagström, Veronika Tillander

|Jul 16, 2025
Treatment patterns and clinical outcomes of patients with hepatocellular carcinoma-a cohort study of 1020 patients in Sweden.

Bonnie Bengtsson, Linnea Widman, Per Stål

|Jun 18, 2025
HCC-surveillance is associated with improved HCC-related mortality in patients with cirrhosis - a case-control study.

Hannes Hegmar, Bonnie Bengtsson, Sofia Ullman

|Nov 01, 2024
Forty years of successful national research collaboration in liver disease - the Swedish experience.

Annika Bergquist, Mattias Ekstedt, Hannes Hagström

Pageof 3